SOD1 and preeclampsia: Lee et al. [76] demonstrated that in vivo localization and the upregulated expression of LOX-1 are associated with reduced placental SOD-1 activity in preeclampsia, which fit perfectly in the well-described phenomenon of increased oxidative stress and reduced antioxidative defense in the preeclamptic placenta.